A possible explanation for these results came from two studies reporting the absence or weak expression of GPC3 in certain breast cancer subtypes due to the silencing of GPC3 by GPC3 promoter hypermethylation [14,28]. This evidence concerns the gene GPC3 and breast carcinoma.